People · Operator
Named in public records as an officer, director or promoter · active 2019–2023 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Human Longevity, Inc. | — | Biotechnology | Series B | $59.0M | $399.4M | 2019 |
David Karow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Karow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Huang | 1 | 5 |
| Wei-Wu He | 1 | 4 |
| James Hu | 1 | 3 |
| Helmut Schuehsler | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.